We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NIU:NASDAQNiu Technologies Analysis

Data as of 2026-07-07 - not real-time

$2.09

Latest Price

8/10Risk

Risk Level: High

Executive Summary

NIU posted a 33.4% revenue surge, lifting total revenue to over $4.5 billion, yet the company remains loss‑making with a trailing EPS of –$0.17 and a negative operating margin of –11.5%. The stock trades at $2.09, well below its 20‑day SMA of $2.14, 50‑day SMA of $2.52 and 200‑day SMA of $3.33, underscoring a bearish technical backdrop. However, the MACD histogram has turned positive and the MACD signal is deemed bullish, hinting at a potential short‑term bounce. Volatility is elevated at 51.5% over the past 30 days and beta stands near 1.7, indicating the share moves sharply with market swings. The forward EPS of $0.20 and a forward P/E of 10.4 suggest the earnings outlook is improving, while the price‑to‑sales multiple of 0.036 points to a deep valuation discount.
Risk factors include a recent max drawdown of nearly 65%, high debt‑to‑equity of 28.5, and exposure to Chinese regulatory shifts, yet the extreme greed sentiment (92.95) and a consensus upside of ~49% to a $3.11 target keep the upside narrative alive.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above the $1.93 support level
  • Bullish MACD histogram despite overall bearish trend
  • Elevated volatility and beta increasing short‑term risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust 33.4% revenue growth driven by domestic sales
  • Forward EPS turning positive and forward P/E of ~10
  • Significant valuation discount (price‑to‑sales 0.036) with upside to $3.11 target

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Long‑term tailwinds in electric micro‑mobility and smart urban transport
  • Persistent operating losses and high debt‑to‑equity ratio
  • Exposure to Chinese regulatory environment and macro‑economic cycles

Key Metrics & Analysis

Financial Health

Revenue Growth33.40%
Profit Margin-2.08%
P/E Ratio10.4
ROE-11.02%
ROA-3.23%
Debt/Equity28.46
P/B Ratio1.4

Technical Analysis

TrendBearish
RSI42.4
Support$1.93
Resistance$2.40
MA 20$2.14
MA 50$2.52
MA 200$3.33
MACDBullish
VolumeStable
Fear & Greed Index92.95

Valuation

Target Price$3.11
Upside/Downside48.84%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.68
Volatility51.51%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.